American Oncology Network Inc. Total Liabilities
American Oncology Network Inc. total liabilities. Based on the latest financial reports, American Oncology Network Inc. (AONC) has total liabilities worth $362.32 Million USD as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check American Oncology Network Inc. (AONC) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of American Oncology Network Inc. (2020–2024)
Total liabilities of American Oncology Network Inc. from 2020 to 2024. This chart illustrates how American Oncology Network Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore American Oncology Network Inc. (AONC) long-term investment share to see how much of total assets are deployed in long-term investments.
American Oncology Network Inc. Competitors by Total Liabilities
The table below lists competitors of American Oncology Network Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
E1 Corporation
KO:017940
|
Korea | ₩13.31 Trillion |
|
Ace Hardware Indonesia Tbk
JK:ACES
|
Indonesia | Rp2.28 Trillion |
|
LINKBANCORP Inc
NASDAQ:LNKB
|
USA | $2.76 Billion |
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
USA | $75.97 Million |
|
Zhejiang Xinguang Pharmaceutical Co Ltd
SHE:300519
|
China | CN¥65.46 Million |
|
Dasheng Times Cultural Investment Co Ltd
SHG:600892
|
China | CN¥477.97 Million |
|
Taiwan Optical Platform Co Ltd
TW:6464
|
Taiwan | NT$9.37 Billion |
|
Shenzhen Longli Technology Co Ltd Class A
SHE:300752
|
China | CN¥1.02 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down American Oncology Network Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see American Oncology Network Inc. asset portfolio.
Liquidity & Leverage Metrics
American Oncology Network Inc. Total Liabilities Ratios Explained
American Oncology Network Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 19.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how American Oncology Network Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for American Oncology Network Inc. (2020–2024)
The table below shows the annual total liabilities of American Oncology Network Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $362.32 Million | +19.29% |
| 2023-12-31 | $303.74 Million | +14.96% |
| 2022-12-31 | $264.21 Million | +1087.12% |
| 2021-12-31 | $22.26 Million | +89395.13% |
| 2020-12-31 | $24.87K | -- |
About American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more